六块爱理不理 8块高攀不起查看全文
格隆汇11月15日丨Aytu BioPharma(AYTU.US)盘前涨18.76%,报0.23美元。公司2023年Q1财报实现营收2765.5万美元,前值为2189.7万美元,预期值为2430万美元,超出市场预期13.81%;每股收益为-0.06美元,前值为-0.33美元,预期值为-0.18美元,超出市场预期66.67%。 网页链接
$Aytu BioScience(AYTU)$ SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals Filed: 2019-09-10 AccNo: 0001193125-19-241442 Size: 38 KB 网页链接
$Aytu BioScience(AYTU)$ 8-K - Current report Filed: 2019-08-02 AccNo: 0001654954-19-008769 Size: 656 KBItem 1.01: Entry into a Material Definitive AgreementItem 9.01: Financial Statements and Exhibits 网页链接
$Aytu BioScience(AYTU)$ 10-Q/A [Amend] - Quarterly report [Sections 13 or 15(d)] Filed: 2019-05-14 AccNo: 0001654954-19-005834 Size: 2 MB 网页链接
$Aytu BioScience(AYTU)$ 8-K - Current report Filed: 2019-05-14 AccNo: 0001654954-19-005838 Size: 285 KBItem 2.02: Results of Operations and Financial ConditionItem 9.01: Financial Statements and Exhibits 网页链接
$Aytu BioScience(AYTU)$ 10-Q - Quarterly report [Sections 13 or 15(d)] Filed: 2019-05-14 AccNo: 0001654954-19-005839 Size: 3 MB 网页链接
$Aytu BioScience(AYTU)$ 美东时间 2019-05-14 盘前 披露财报,预期EPS -0.61 网页链接
$Aytu BioScience(AYTU)$ 8-K - Current report Filed: 2019-05-02 AccNo: 0001654954-19-005160 Size: 86 KBItem 1.01: Entry into a Material Definitive AgreementItem 9.01: Financial Statements and Exhibits 网页链接
$Aytu BioScience(AYTU)$ 8-K - Current report Filed: 2019-04-26 AccNo: 0001654954-19-004897 Size: 72 KBItem 1.01: Entry into a Material Definitive AgreementItem 7.01: Regulation FD DisclosureItem 9.01: Financial Statements and Exhibits 网页链接
$Aytu BioScience(AYTU)$ SC 13D/A [Amend] - General statement of acquisition of beneficial ownership Filed: 2019-04-23 AccNo: 0000919574-19-003012 Size: 125 KB 网页链接
$Aytu BioScience(AYTU)$ 8-K - Current report Filed: 2019-04-19 AccNo: 0001654954-19-004590 Size: 46 KBItem 1.01: Entry into a Material Definitive AgreementItem 3.02: Unregistered Sales of Equity Securities 网页链接